Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02013323Phase 2Completed
Phase 2, randomised, double-blind trial in chronic periodontitis comparing Septilin Group with Placebo Group (2 arms). Primary endpoint: Clinical Attachment Level at 6 months. Started Mar 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02013323.